# Chantix Settlement

Pfizer settled allegations that it sold the smoking-cessation drug Chantix that was allegedly affected by the issues described in the litigation. Pfizer denies any wrongdoing and the court made no finding of liability.

A settlement for people who bought Chantix in the United States between September 29, 2015 and September 17, 2021. Consumers who file a claim share the settlement fund, paid on a pro rata basis according to how much they paid.

| Field | Detail |
| --- | --- |
| Defendant | Pfizer |
| Total settlement | $44,000,000.00 |
| Estimated payment | Consumers who submit a Claim Form receive a pro rata share based on the amount they paid for Chantix, capped at 20% of the Available Settlement Fund. Payments depend on the number and size of valid claims. |
| Claim deadline | 2026-09-14 |
| Who is eligible | Consumers who purchased Chantix in the United States and its Territories from September 29, 2015 through September 17, 2021. |
| Proof required | Proof of purchase supports a claim. The Claim Form explains what is accepted; you can submit it online or by mail. |
| Official claim site | https://chantixsettlement.com/ |

To claim, follow the link to the official site and file there. We never file for you.

## Sources

Verified 2026-07-28.
- Official Settlement Website — Chantix Class Action Settlement (United States District Court for the Southern District of New York) (A.B. Data, 2026) — https://chantixsettlement.com/

---

This information is not a substitute for legal advice.